<style face="normal" font="default" size="100%">Response to: Correspondence on 'Novel imaging biomarkers predict outcomes in stage III unresectable non-small cell lung cancer treated with chemoradiation and durvalumab' by Zheng <em>et al</em></style>

Drupal-HighWire